22/07/2025 Replimune's BLA for vusolimogene oderparepvec + nivo received a CRL from the US FDA ( Ref ) The US FDA issued a Complete...

June 4th Week,2025 Regulatory Events 🎯 Daiichi Sankyo and AstraZeneca 's Dato-DXd (Datroway; TROP2 ADC) has been granted an...

24/06/2025 Opdivo + Yervoy received supplemental approval in Japan to expand the use for unresectable hepatocellular carcinoma ( Ref )...